tradingkey.logo
マヌケット
ニュヌス
分析
ツヌル
株匏スコア
株匏スコア



English
繁䜓䞭文
à¹„àž—àž¢
Tiếng việt
简䜓䞭文
Español
Português
Deutsch
한국얎
日本語

tradingkey.logo



Genenta Science SPA

GNTA
0.630USD
-0.080-11.23%
終倀 03/30, 16:00ET15分遅れの株䟡
11.42M時䟡総額
損倱額盎近12ヶ月PER


Genenta Science SPA

0.630
-0.080-11.23%
抂芁金融分析䌁業名

抂芁

金融

分析

䌁業名

詳现情報 Genenta Science SPA 䌁業名

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

Genenta Science SPAの䌁業情報


䌁業コヌドGNTA
䌚瀟名Genenta Science SPA
䞊堎日Dec 15, 2021
最高経営責任者「CEO」Paracchi (Pierluigi)
埓業員数13
蚌刞皮類Depository Receipt
決算期末Dec 15
本瀟所圚地Via Olgettina 58
郜垂MILANO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Italy
郵䟿番号20132
電話番号
りェブサむトhttps://www.genenta.com/
䌁業コヌドGNTA
䞊堎日Dec 15, 2021
最高経営責任者「CEO」Paracchi (Pierluigi)

Genenta Science SPAの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
+0.28%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+9.93%
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Finance Director
Finance Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
+0.28%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+9.93%
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Paracchi (Pierluigi)
9.83%
IRCCS Ospedale San Raffaele
8.09%
Naldini (Luigi M.D., Ph.D.)
5.92%
Gentner (Bernard)
2.96%
Citadel Advisors LLC
2.80%
他の
70.41%
株䞻統蚈
株䞻統蚈
比率
Paracchi (Pierluigi)
9.83%
IRCCS Ospedale San Raffaele
8.09%
Naldini (Luigi M.D., Ph.D.)
5.92%
Gentner (Bernard)
2.96%
Citadel Advisors LLC
2.80%
他の
70.41%
皮類
株䞻統蚈
比率
Individual Investor
21.49%
Corporation
8.09%
Hedge Fund
6.92%
Investment Advisor
4.58%
Investment Advisor/Hedge Fund
1.60%
Holding Company
1.00%
Sovereign Wealth Fund
0.97%
Research Firm
0.20%
Bank and Trust
0.01%
他の
55.14%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
19
1.83M
9.54%
-414.06K
2025Q3
16
1.96M
10.22%
-334.32K
2025Q2
24
9.06M
49.52%
-260.05K
2025Q1
28
9.12M
49.85%
-26.40K
2024Q4
28
8.70M
47.57%
-293.74K
2024Q3
26
8.60M
47.05%
-368.88K
2024Q2
26
8.48M
46.40%
-155.29K
2024Q1
25
8.51M
46.63%
+417.20K
2023Q4
25
8.38M
45.98%
+434.51K
2023Q3
24
8.11M
44.52%
+167.75K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Paracchi (Pierluigi)
2.30M
11.99%
-3.10K
-0.13%
Mar 26, 2025
IRCCS Ospedale San Raffaele
1.90M
9.91%
--
--
Mar 26, 2025
Naldini (Luigi M.D., Ph.D.)
1.39M
7.24%
--
--
Mar 26, 2025
Gentner (Bernard)
692.87K
3.62%
--
--
Mar 26, 2025
Citadel Advisors LLC
12.49K
0.07%
+12.49K
--
Sep 30, 2025
Russo (Carlo)
602.42K
3.15%
+4.00K
+0.67%
Mar 26, 2025
Eurizon Capital SGR S.p.A.
360.00K
1.88%
--
--
Nov 30, 2025
Investitori SGR S.p.A.
234.05K
1.22%
--
--
Nov 30, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™